Literature DB >> 2052314

Laboratory confirmation of African horsesickness in the western Cape: application of a F(ab')2-based indirect ELISA.

D H Du Plessis1, W Van Wyngaardt, G H Gerdes, E Opperman.   

Abstract

Recently a suspected outbreak of African horsesickness in the Western Cape Province resulted in the deaths of four foals and one adult horse. Spleen samples from these animals were subjected to analysis by an enzyme-linked immunosorbent assay (ELISA) which uses F(ab')2 fragments of immunoglobulins to detect African horse sickness virus (AHSV) antigens. The results of the immunoassay were compared with those obtained by isolation followed by serotyping as is currently applied by the Reference Centre at the Veterinary Research Institute, Onderstepoort. Samples of spleen tissue from the four foals contained sufficient antigen to be readily detectable by ELISA. A marginally positive signal was obtained with the tissue from the adult horse. This sample was inoculated onto VERO cells and four days were allowed for viral multiplication. Subsequently, when the cell culture was assayed by F(ab')2-ELISA, a much higher absorbance value than that obtained with the original spleen sample resulted, thus confirming the presence of AHSV in the initial specimen. The F(ab')2-ELISA has potential to be used as an initial diagnostic test to screen for AHSV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052314

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  2 in total

1.  Detection of African horse sickness virus by reverse transcription-PCR.

Authors:  M Stone-Marschat; A Carville; A Skowronek; W W Laegreid
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

2.  Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

Authors:  Rachael Chiam; Emma Sharp; Sushila Maan; Shujing Rao; Peter Mertens; Barbara Blacklaws; Nick Davis-Poynter; James Wood; Javier Castillo-Olivares
Journal:  PLoS One       Date:  2009-06-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.